Webinars

Webinar: Advanced Therapy Conundrum: Should You Build, Outsource, or Go Hybrid?

June 9, 2021

Webinar: Advanced Therapy Conundrum: Should You Build, Outsource, Or Go Hybrid? June 22, 2021. 2:00PM EST/ 7.00PM GMT Companies developing

Webinar: Launching an RX Product in the EU

December 7, 2020

Webinar: Launching an RX Product in the EU Fail to Prepare, Prepare to Fail [January 27, 2021. 4:00PM GMT/11:00AM EST]

Pharmaceutical Business Continuity Plan as a Key Component of COVID-19 Pandemic Response

May 20, 2020

“To be a proper business continuity plan, a company needs to roll it out across its entire organization, there

North American Office

EMA Labelling and Packaging Regulations

Introduction The European Medicines Agency (EMA) is a decentralised agency of the European Union (EU) in charge of scientific evaluation, regulation, and quality control of

EU Marketing Authorization Procedures

European Medicines Agency The European Medicines Agency (EMA) is responsible for the scientific evaluation of centralized marketing authorization applications (MAA’s). A marketing authorization (MA) is the authorization

Webinar: Advanced Therapy Conundrum: Should You Build, Outsource, or Go Hybrid?

Webinar: Advanced Therapy Conundrum: Should You Build, Outsource, Or Go Hybrid? June 22, 2021. 2:00PM EST/ 7.00PM GMT Companies developing advanced therapies have to decide

Website by Propeller Digital and BuyMedia

Webinars

Webinars

Webinar: Advanced Therapy Conundrum: Should You Build, Outsource, or Go Hybrid?

Webinar: Launching an RX Product in the EU

Pharmaceutical Business Continuity Plan as a Key Component of COVID-19 Pandemic Response

European Office

UK Office

North American Office

EMA Labelling and Packaging Regulations

EU Marketing Authorization Procedures

Webinar: Advanced Therapy Conundrum: Should You Build, Outsource, or Go Hybrid?